Search 1
Entities
LogoName Σ Employees
Step Pharma Step Pharma

Developing selective inhibitors of CTPS1 for patients with cancer and auto-immune diseases Step Pharma is the world leader in the discovery and development of inhibitors of CTPS1 (cytidine triphosphate synthase 1) for the treatment of cancer and autoimmune diseases. Step Pharma’s lead program dencatistat (STP938) is a first in class, potent, selective, oral inhibitor of CTPS1 with demonstrated anti-tumor activity. Dencatistat entered clinical development in 2022 in a PhI/II study for the treatment of relapsed and refractory T-cell and B-cell lymphoma. More recently a solid tumour study was started focused on ovarian cancer using the concept of synthetic lethality and …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

1 0 0 16
NUTRIFIZZ NUTRIFIZZ

[Automatic translation follows] A pioneer, Nutrifizz is a scientific and technical design office that places health nutrition at the heart of research and innovation projects for players in the food chain. Created by two doctors in nutrition, Céline GRYSON and Emilie CHANSEAUME, Nutrifizz is committed to providing depth through science, to engage in future themes in the field of innovation by surrounding itself with the best partners. Our leitmotif: Co-constructing the resolution of the science, regulation, market equation! Beyond their cross-disciplinary knowledge, our project managers have specific scientific expertise in connection with the future challenges of nutrition, such as plant …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

17 9 11 5
MAbSilico MAbSilico

The only TechBio providing computationally designed antibodies through AI with biological validations associated MAbSilico is a TechBio company developing and providing AI-based solutions for antibody drug design and discovery. We help biotech and pharma companies to leverage antibody discovery risks by providing computational candidates in days which are designed and characterized in silico and validated with state-of-the-art biological technologies. While MAbSilico combines 3D modeling, interaction simulation and linear sequences analysis, the antibody drug candidates are defined through their epitope, affinity, off-target risk, cross-species reactivity and developability assessment to be ready for biological activity evaluation. Using NLP technologies we gather information …

Type: Startup Activities: deeptech biotech Technologies: A.I. A.I. - Natural Language Processing Synthetic Biology

16 3 11 13
EYEVENSYS EYEVENSYS

We create ophthalmic therapeutic bio factories to sustainably treat major eye diseases. Eyevensys is a clinical stage, private, biotechnology company developing its innovative EyeCET platform to enable the sustained intraocular production of therapeutic proteins to treat a broad range of ophthalmic disease. EyeCET stands for the eye ciliary muscle electro-transfection technology, which uses electroporation to deliver plasmids coding for therapeutic proteins in the eye. EyeCET is safe and non-viral, and it enables the ciliary muscle cells to sustainably produce therapeutic proteins locally. Eyevensys believes its EyeCET technology can improve short and long-term therapeutic outcomes, greatly enhancing patient compliance and significantly …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 8
Medical Device Engineering Medical Device Engineering

MEDICAL DEVICE ENGINEERING S.A.S to bring innovators the missing link in the development of their medical devices. We created MEDICAL DEVICE ENGINEERING S.A.S to bring innovators the missing link in the development of their medical devices and disposables.  The concept of your therapy, or surgery has been proven from the medical point of view (PoC) and you need a device?  Or you may simply have an idea and do not know where to start to make it concrete? Our Philosophy: A team composed of both Scientists & Engineers (plastics processing) to better understand each other, and to make …

Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology

0 0 0 3
Pharm'image Pharm'image

#Pharmaco-imaging, #nuclear medicine, #PET/MRI, #Radiochemistry, #Preclinical models Created in 2008 in Dijon, Pharm’image is a regional center of excellence in Pharmaco-imaging. Unique in France, it brings together hospitals, biotechnology, and pharmaceutical companies, to offer state-of-the-art of functional and molecular imaging technologies (MRI, PET, SPECT, CT), ranging from small-animal scale for preclinical experimentation to clinical exploitation Its aim is to deploy cutting-edge medical imaging technologies to evaluate biomarkers that can be used to track treatment efficacy and select the active and most promising drug candidates. imaging, preclinical evaluation, pharmacology, molecular imaging, nuclear medicine, radiochemistry, bioconjugation, translational research, in vivo pharmaco-imaging, First …

Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

0 0 0 1
SUPERBRANCHE SUPERBRANCHE

Nanomaterials as Nanomedicines: let's play collective! SUPERBRANCHE : Nanomedicine as a breakthrough to treat cancer We bring answers to the following issue: intratumoral injection of nanomaterials implying both accessibility and detection of the tumor beforehand. We position ourselves as a producer dedicated to the synthesis of architectured nanomaterials as simple as possible and of controlled size. Our modular technology platform presents both therapeutic and diagnosis applications. It consists in a magnetic nanoparticle coated by a tailor made branched architecture. Thanks to their optimized shape and stability, our compounds are well tolerated and can be administered intravenously, thus helping to the …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

14 6 7 10
PKDERM PKDERM

Smart innovative solutions in dermatology and respiratory diseases Welcome to PKDERM - Your Trusted Partner for In Vitro Safety and Efficacy Solutions. PKDERM is a leading provider of innovative and effective solutions for in vitro efficacy and safety testing of new products. Our team of experts has years of experience in the industry, and we are committed to delivering the highest level of quality and support to our clients. At PKDERM, we specialize in in vitro safety and efficacy testing, using a range of biological models such as 2D and 3D human skin equivalent models, excised human skin, 2D and …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

5 2 4 2
Cible Skin Cible Skin

[Automatic translation follows] Expert in skin health and beauty Cible Skin is the alliance of medical expertise, cutting-edge technology and science, in order to preserve the health and beauty of all skin types. Instagram: https://www.instagram.com/cibleskin.paris/ Medical-cosmetic care and treatments for the face, body and hair, Sale of cosmeceuticals, Training of aesthetic doctors, and Aesthetic facial care

Type: Startup Activities: deeptech cosmetics Technologies: Synthetic Biology

0 0 0 37
PulseSight Therapeutics PulseSight Therapeutics

PulseSight is an ophthalmology drug development company developing disruptive non-viral gene therapies with minimally-invasive delivery technology to treat major eye diseases. Our mission is to develop life-changing solutions for patients with diseases leading to sight loss.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

2 0 2 7
CSV Experts CSV Experts

Always Meeting the Standards Computerized Systems Validation Experts. Consultancy services for healthcare regulated companies with regards computerized systems validation in GXP environments. The most valued services delivered in compliance with EU GMP and 21 CFR Part 11. Contact at info@csvexperts.com Strategies for the fulfillment of the GMP and GDP regulations, Strategies for the fulfillment of regulatory needs and quality assurance in the areas of R&D, Medical Devices, IT Compliance, Audits, and Business training

Type: Startup Activities: deeptech healthtech it services Technologies: Synthetic Biology

2 1 1 7
McSAF McSAF

Chemical tools for bioconjugaison & biodrugs McSAF is a Deeptech company specialized in Bio-Organic & Bio-Conjugates Chemistry, developing innovative technologies for improved targeted therapies. Its core expertise covers Therapeutic Peptides and Proteins, Antibodies, and Drug Conjugates. The team has a strong background in synthetic selective chemistry, and a real expertise in bioconjugation, including specific designs of Antibody Drug Conjugates (ADCs) with own proprietary coupling technology. Plus, the company has now a pipeline of three products in oncology incorporating McSAF Inside technology with the ambition to bring new biodrugs on the market solving unmet medical needs. Bioconjugation, Biopharmaceuticals, Antibody Drug Conjugates, …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

1 1 0 6
Molecular Devices Molecular Devices

Advancing Discovery Molecular Devices is one of the world’s leading providers of high-performance life science technology. We make advanced scientific discovery possible for academia, pharma, and biotech customers with platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. From cancer to COVID-19, we've contributed to scientific breakthroughs described in over 230,000 peer-reviewed publications. Over 160,000 of our innovative solutions are incorporated into laboratories worldwide, enabling scientists to improve productivity and effectiveness – ultimately accelerating research and the development of new therapeutics. Molecular Devices is headquartered in Silicon Valley, Calif., with best-in-class teams around the globe. Over …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

3 1 2 765
Medscape Medscape

The leading online global destination for physicians and healthcare professionals: https://wb.md/2EPrMgZ Our Mission: To improve patient care with comprehensive clinical information and resources essential to physicians and healthcare professionals. Our Company: Medscape is the leading online global destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives; essential point-of-care drug and disease information; and relevant professional education and CME. Medscape has over 30 distinct specialty sites for physicians, plus sites for nurses, pharmacists, dentists, and medical students. All content on Medscape.com and Medscape.org is available for free. medical news, medical reference, and continuing medical education

Type: SMB Activities: healthtech Technologies: Synthetic Biology

12 5 3 762
Viridos Viridos

See how algae moves us. Viridos is a privately held biotechnology company harnessing the power of photosynthesis to create transformative solutions to mitigate climate change. Our unparalleled understanding of algal genetics and ability to translate innovation from lab to field underpins our initial deployment: a scalable platform to produce low-carbon intensity biofuels for aviation, commercial trucking, and maritime shipping. Building on a legacy of genomic firsts, our team of scientists and engineers are shaping new pathways toward a sustainable bioeconomy. To learn more, visit us at Viridos.com. Synthetic Biology, Fermentation, Next Generation Genomics, Bioprocessing, Bioinformatics, Cell Optimization, Biodiscovery, Advanced Engineering, …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

5 0 5 83
Medicago Medicago

La santé est dans notre nature | Health is in our nature. Medicago develops vaccines and treatments to help fight emerging global health challenges, today and in the future. Please note that we may come across a situation not outlined above that will require the removal of your comment. Please know that Medicago reserves the right to delete any comment at its sole discretion. If you feel your comment has been unfairly removed, please contact us. For information about our commenting guidelines, please visit: http://ow.ly/6mKh50HKyUR Medicago développe des vaccins et des traitements pour répondre rapidement aux nouveaux défis de santé …

Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

5 0 1 180
Medgadget Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004. Medgadget is an independent publication and is published by a group of MDs and biomed engineers. If you have collaboration ideas or entrepreneurial experience that you want to bring to our company's attention, we want to hear from you. We believe that possibilities at Medgadget are endless! medical devices, medical discoveries, medical technology, conferences, medicine, events, and publishing

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

3 0 0 10
Master Spas Master Spas

Get the backyard oasis you’ve always wanted with a Master Spas ultra-therapeutic hot tub or swim spa Master Spas is based in Fort Wayne, Indiana, 90 miles northeast of Indianapolis. Operating out of a state-of-the-art, 530,000-square-foot manufacturing facility on a 36-acre manufacturing campus, Master Spas is the largest swim spa manufacturer in the world, and largest portable hot tub manufacturer that makes 100% of our product in the USA. The company’s executive team boasts more than 200 years of spa manufacturing success and one of the strongest track records in the industry. The company is committed to helping people live …

Type: SMB Activities: edtech Technologies: Synthetic Biology

0 0 0 188
Marymound Marymound

Helping youth and families with the challenges of growing and learning to achieve independence while realizing their full potential. Clinical Therapy, Group Homes, Sexual Exploitation, Crisis Stabilization, Special Needs Education, Drug Addiction, Independent Living, Young Parents, Mental Health, Foster Care, Sexual Abuse, and Employment Training

Type: SMB Activities: edtech healthtech Technologies: Synthetic Biology

2 1 1 148
Optomed Plc Optomed Plc

Finnish MedTech company and a leading provider of handheld fundus cameras enabling screening for all. Optomed is a Finnish medical technology company and a leading provider of handheld fundus cameras. Our AI-powered screening solutions aim to transform diagnostic processes of various diseases, empower early detection, and improve people’s health through innovations. Two decades of pioneering expertise, we design cutting-edge retinal imaging technology that is trusted by healthcare professionals worldwide. Our technology is extensively patented, clinically validated and has approvals in all key markets, including CE, FDA and CFDA. Our products are sold via various sales channels in over 60 countries …

Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

0 0 0 90
Integrum AB Integrum AB

Improving life for amputees through bone-anchored prostheses, healthy soft tissue and relief of phantom limb pain. Integrum has since the start in 1998 been helping individuals with amputations towards an improved quality of life. A thorough experience in osseointegration has generated a system for bone-anchored prostheses – a beneficial alternative to the traditionally used socket prosthesis. Integrum is world leading in this area, with patients from all parts of the world treated in centers of excellence. Performing continuous research and development, Integrum aims at providing safe medical devices and supporting a more active lifestyle for those experiencing limb loss. In …

Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

0 0 0 63
CHEPLAPHARM CHEPLAPHARM

A Sustainable Platform for Specialty Pharma. As a globally operating company headquartered in Germany, CHEPLAPHARM has established a leading and sustainable platform for specialty pharma during the past two decades. We invest worldwide in well-established pharmaceutical brands which have been developed and introduced by research-based pharmaceutical companies. Our deep expertise in this field enables us to sustain the value of these brands for patients and the medical community. In this way we help the research-based pharmaceutical industry divest from older products so they can focus resources on innovation and new product pipelines. This is how we ACHIEVE MORE together. Specialty …

Type: SMB Activities: deeptech Technologies: Synthetic Biology

1 0 0 417
Laboratoire Shadeline Laboratoire Shadeline

[Automatic translation follows] Development & production of safe and effective medical devices and dermo-cosmetic products for the whole family. SHADELINE Laboratory is an entity of the ANJAC HEALTH & BEAUTY Group. Specialized in Research & Development and Production of dermocosmetic, parapharmaceutical products and medical devices for topical use. Characterized by a high level of technicality and quality, the laboratory is certified ISO 22716 (GMP cosmetics) and ISO 13485 (Design, Development and Production of Medical Devices). SHADELINE creates and manufactures all types of innovative and effective formulations for dermatological products: Baby products, sun products, hygiene and beauty products, skin disorder correction …

Type: SMB Activities: cosmetics healthtech manufacturing Technologies: Synthetic Biology

0 0 0 28
Europhartech - A Dômes Pharma Company Europhartech - A Dômes Pharma Company

[Automatic translation follows] Europhartech, a company of the Dômes Pharma Group Production site of the Dômes Pharma Group EUROPHARTECH is also a CMO (Contract Manufacturing Organization) for the Human and Veterinary Pharmaceutical Industry. Specialized in clinical batches, the production of dry forms and non-sterile liquid forms for human and veterinary use as well as in food supplements, complementary foods and medical devices. EUROPHARTECH also has solid expertise in the originator markets, ATU/AMM hospital and EHPAD unit BUD, PDA, generic and nutraceutical. EUROPHARTECH is a subsidiary of the DÔMES PHARMA Pharmaceutical Group historically specialized in Animal Health and present in Human …

Type: SMB Activities: deeptech biotech manufacturing Technologies: Synthetic Biology

2 1 0 75
C4X Discovery Ltd C4X Discovery Ltd

Pioneering drug discovery company exploiting cutting edge technologies to create best-in-class small molecule medicines C4XD is a pioneering Drug Discovery company, combining scientific expertise with cutting-edge technologies to efficiently deliver world‐leading medicines. We have a highly valuable and differentiated approach to Drug Discovery through our enhanced molecular design and patient stratification capabilities, generating small molecule drug candidates across multiple disease indications focused on immuno-inflammation. The Company was founded as a spin-out from the University of Manchester. It has a highly experienced management team and Board who have delivered significant value creation within the healthcare sector historically and have enabled C4XD …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

7 1 4 47
Cumulus Neuroscience Cumulus Neuroscience

Accelerating CNS Clinical Trials We’re developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience.

Type: Startup Activities: healthtech Technologies: Synthetic Biology Data Analytics

5 2 0 33
Healthy Performance Ltd Healthy Performance Ltd

Employee Health and Wellbeing Specialists We are passionate about improving employee health and wellbeing through our range of innovative and easy to use workplace solutions. With powerful reporting and insight tools we can help to maximise the impact of wellbeing solutions which ultimately leads to happy and healthy employees. We provide onsite health assessments, online lifestyle and mental health checks, onsite health promotion events, wellbeing workshops and webinars, flu vaccination services and Covid-19 antibody testing services. All of our onsite staff follow strict PPE processes and protocols in line with Public Health England to ensure Covid-19 workplace safety. Our in-depth …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

3 1 1 35
Aqdot Limited Aqdot Limited

The Supramolecular Chemistry Company Aqdot is a Cambridge (UK)-based supramolecular chemistry company with a focus and expertise in developing, licensing and selling novel proprietary products. The Aqdot Solutions part of the business works in partnership with customers to understand their challenges and develop solutions utilising the unique AqBit technology. This has the team working in areas from air filtering in transportation to delivery of therapeutics for cancer. In parallel the Aqdot Products part of the company has recently launched its own brands AqStarTM M1 and Oderase to date. Again, working with partners either on a distribution basis, or offering the …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

2 1 1 30
CytoSeek CytoSeek

A cell-therapy technology company developing artificial membrane-binding proteins for oncology and regenerative medicine CytoSeek's mission is to use cell membrane augmentation technology to unlock the potential of next generation advanced therapies. Our novel cell membrane augmentation technology enables us to add new functionalities to various therapeutic cells. CytoSeek is engaged in proof of principle studies to demonstrate enhancement of cell therapies for cancer. We are looking to partner with cell therapy companies to bring these products to the clinic and ultimately enhance human health. Biochemistry, Immunology, Oncology, Regenerative Medicine, Cell therapies, and Proteins

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 2
Corin Group Corin Group

Helping orthopaedic surgeons enhance patient well-being with our proven implants, connected technologies and data. As a leader in orthopaedic innovation, Corin has pioneered a number of landmark developments since its foundation and is proud to have been able to improve the quality of life of thousands of patients around the world through these groundbreaking products. The company’s talented and dedicated teams share a common commitment to deliver quality orthopaedic products and services to patients, surgeons and healthcare providers which exceed expectations and positively impact lives. With an increasingly active and demanding patient population, the need to provide state of the …

Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology

1 0 0 712
Venomtech Ltd Venomtech Ltd

Our goal at Venomtech is to lead the way towards an era where venom-based research tools are routinely used as sources Venomtech targeted arrays provide a unique opportunity to identify novel screening tools and discover novel therapeutics. Animal venoms are a complex mix of peptides, small molecules and proteins that bind, activate, inhibit or otherwise modulate molecular targets such as ion channels, GPCRs and kinases. Screening crude venoms to identify bioactive components is made extremely difficult by a large number of potentially conflicting activities (e.g. cytotoxins masking pharmacology) and de-convolution challenges. In the past, these challenges have hampered many of …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

2 0 2 6
CERHUM CERHUM

Bone graft 3D-printing | bioceramics | R&D | CDMO activities CERHUM AT A GLANCE: We are a Belgian company which manufactures human bone grafts made of bio ceramics and act as a Medical Device CDMO, providing thousands of parts and developments as a subcontractor for big players, mainly in orthopedic surgeries. ---------------------------LEARN MORE---------------------------------- CERHUM manufactures medical devices using additive manufacturing (3D printing) in combination with advanced and innovative materials. With a 10 year-experience of industrial and in-house R&D, CERHUM has applied these additive manufacturing capabilities to bioceramics and in particular hydroxyapatite which is a well-known, tried and tested material in …

Type: Startup Activities: deeptech industry 4.0 healthtech manufacturing Technologies: 3D Printing Synthetic Biology

0 0 0 23
Pi-Cardia Pi-Cardia

Leading the way for leaflet modification Pi-Cardia is a medical device company and market leader in the development of a broad portfolio of leaflet modification solutions for treating heart valves. The company has years of knowledge and expertise accumulated in degenerated valves, including calcification patterns, mode of valve failure, and impact of various methods of leaflet modification. ShortCutTM is designed to provide a safe, simple, and effective way to split leaflets of a pre-existing valve to enable TAVR in patients at risk for coronary obstruction and may assist in preserving coronary access. Medical Device, Aortic Stenosis, Precautions Catheter-System, Cardiovascular, leaflet …

Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

2 1 1 58
STH BIOTECH STH BIOTECH

Unlocking the access to innovative ingredients and APIs from cannabis, thanks to plant biotechnology. STH BIOTECH develops unique and reliable plant-biotech process to produce cannabinoids at high yield & low cost.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

14 6 12 11
Oxyledger Oxyledger

Reinvent the traceability of implantable medical devices to democratize and simplify clinical follow-up Our mission: Build secured and protected global Medical Device Health Registry by collecting data at the point of use in the Operating Room for practicing evidence-based medicine and tracing implantable devices to protect patient safety and meet regulatory compliance. Traçabilité, Santé, Prothèses, Dispositifs médicaux, Implants, DMI, IUD, DM, Wiki, Bloc opératoire, GS1, UDI, and Wiki

Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology

9 3 9 9
Gene&GreenTK Gene&GreenTK

Enzymes for agricultural transition Gene&GreenTK (GGTK) is a biotech company created in 2013 and incubated in the IHU of Marseille. The work of GGTK is dedicated to the development and engineering of innovative enzymes isolated from microorganisms living in extreme environments. Enzymes developed by GGTK have two main applications: - Anti-virulence and anti-biofilm for the development of sustainable alternative to conventional antimicrobial agents targeting applications in agriculture, animal nutrition or anti-fouling. - Bioremediation of organophosphorus chemicals for the degradation of insecticides and chemical warfare agents. enzyme, protein engineering, Quorum quenching, organophosphorus decontamination, bioremediation, anti-fouling, biofilm, bacterial virulence, biocatalysis, extremophiles, lactonase, …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

5 1 0 12
INDIENOV INDIENOV

[Automatic translation follows] Innovate to protect INDIENOV (commercial brand of HIPPY MS) designs and develops medical devices based on built-in electronics and artificial intelligence in order to extend the quality of life and independence of elderly people. INDIENOV (commercial brand of HIPPY MS) is an innovative company combining human and digital to save lives and serve better living. Its purpose, as a mission-driven company, is to contribute to the independence and promote the autonomy of people at risk by innovating in all ways. We act in this way to improve the safety, serenity and existence of people at risk and …

Type: Startup Activities: healthtech manufacturing Technologies: Synthetic Biology

36 12 26 20
The Healthy Pet Company The Healthy Pet Company

The best health care for your pet. Join today to spread the cost. Our pet health care plans for cats, dogs, rabbits, puppies and kittens help you to save money on your pet’s vital preventative health care.

Type: Startup Activities: pettech foodtech healthtech Technologies: Synthetic Biology

0 0 0 1
VETS IN THE CITY VETS IN THE CITY

Pet Care Remaining your partner for honest, compassionate and complete pet healthcare. Our services and facilities have been designed to assist in all routine preventative care for young, healthy pets; early detection and treatment of disease as your pet ages; and complete medical and surgical care as necessary during their lifetime. veterinary

Type: SMB Activities: pettech healthtech Technologies: Synthetic Biology

0 0 0 6
Jelmar, LLC Jelmar, LLC

Been There. Outdone That.TM Jelmar manufacturers CLR Brands and Tarn-X branded cleaning products. These products are available in food, drug and mass retailers. Jelmar has been a growing, evolving company since its inception in 1949. The company began when Manny Gutterman established a national sales representative organization, Manny Gutterman & Associates, Inc. This new company was dedicated to selling all types of proprietary products to chain drug, variety, hardware and department stores. Tarn-X® Tarnish Remover, during the late 1960s, became one of the first products that used the phrase “AS SEEN ON TV” in commercials and on packaging. Tarn-X has …

Type: SMB Activities: deeptech manufacturing Technologies: Synthetic Biology

0 0 0 30
Labovet Produtos Veterinários Labovet Produtos Veterinários

[Automatic translation follows] For over 30 years, we have been a reference in the production of vaccines and veterinary products. We are proud to be 100% Brazilian. Labovet is a pharmaceutical company that offers medicines and vaccines for small, medium and large animals. For over 30 years, our focus has been on animal health, through products with high quality standards and constant investments in research and modernization of our factory. We operate throughout Brazil with distribution centers in strategic locations in the country, in order to have the best delivery conditions and guarantee the proper packaging of our products. Biologicals, …

Type: SMB Activities: pettech deeptech biotech Technologies: Synthetic Biology

0 0 0 181
IndyHumane IndyHumane

Adoptions, foster, volunteer & youth programs, low-cost vaccines & spay/neuter. We've been saving lives since 1905. IndyHumane provides direct services for cats and dogs, including adoption, foster home placement, positive reinforcement behavior training for adoptable animals, appropriate medical care, and affordable spay/neuter and low-cost vaccination services to the public. In 2019, supported by more than 600 volunteers, we provided services to more than 10,000 dogs and cats, found loving homes for more than 3,800 homeless pets, and achieved a live release rate of 96%. As a limited intake shelter, we take in as many animals as we can save every …

Type: SMB Activities: pettech healthtech Technologies: Synthetic Biology

3 1 3 75
F-star, an invoX company F-star, an invoX company

A clinical-stage biopharma developing next gen bispecific antibodies to transform the lives of patients with cancer. F-star, an invoX company, is a clinical-stage biopharmaceutical business pioneering bispecific antibodies in immunotherapy so more people with cancer can live longer and improved lives. F-star is committed to working towards a future free from cancer and other serious diseases through the use of tetravalent (2+2) bispecific antibodies to create a paradigm shift in treatments. F-star has four second-generation immunooncology therapeutics in the clinic, each directed against some of the most promising IO targets in drug development, including LAG-3 and CD137. F-star’s proprietary antibody …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

7 1 4 43
Takeda in Belgium Takeda in Belgium

Better Health, Brighter Future Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history, originating in Japan. As a global leader with presence in over 80 countries and regions, our therapeutics focus on Gastro-enterology, Oncology, Rare Diseases, Neuroscience, Plasma-Derived Therapies and Vaccines. In Belgium, Takeda is one of the 10 largest pharmaceutical companies, with its local head office located in Zaventem, close to Brussels Airport. Day after day, our …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

5 2 3 257
Hendrix Genetics Hendrix Genetics

Better Breeding Today. Brighter Life Tomorrow. Hendrix Genetics is a leading multi-species animal breeding company with primary activities in layer-, turkey-, traditional poultry-, swine-, trout and salmon breeding. Backed by a strong portfolio of leading brands, Hendrix Genetics provides expertise and resources to producers in more than 100 countries, with operations and joint ventures in 24 countries and more than 2.880 employees worldwide. Creating value with genetics is the essence of our existence. The three key components of how we create value for the animal protein chain are: collaboration, innovation and sustainability. We see collaboration as a key factor in …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

3 1 0 669
Horus Pharma Horus Pharma

Horus Pharma is an independent French laboratory specialised in ophthalmology. Founded in 2003, Horus Pharma develops, patents and markets products designed to facilitate eye and eyelid health. Horus Pharma operates in most segments related to ophthalmology and develops practical innovations that combine efficacy and safety. Read our community guidelines https://bit.ly/HPCommunityGuidelines Focused on patient safety, our laboratory has developed recognised expertise in the development of preservative-free formulations and product delivery systems. The product portfolio at the laboratory includes medicinal products, medical devices and food supplements. With its new Surgery Division, Horus Pharma is pursuing its growth by offering surgical and peri-surgical …

Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

20 3 18 245
CYRANIE NUTRITION CYRANIE NUTRITION

[Automatic translation follows] For 20 years, Cyranie has made taste its central concern, our very diversified products adapt to the appetites and requirements of each person and promote the pleasure of eating. Cyranie develops, manufactures and markets a range of dehydrated food mixes. Cyranie has always based its approach on taste and nutritional qualities in accordance with French tradition and culinary know-how. We are manufacturers, our products are exclusive and developed by our R&D department in close collaboration with our customers. Cyranie has veterinary approval, works according to the HACCP method and since 2014 has obtained the IFS v6 superior …

Type: SMB Activities: foodtech Technologies: Synthetic Biology

3 1 2 6
Crystal Pharmatech Crystal Pharmatech

A Leading CRO/CDMO for Solid Form & Formulation, Advancing Your PCC to Phase I and Beyond with First-Time-Right Approach Established in 2010, Crystal Pharmatech is a specialized CRO/CDMO, excelling in crystal form and formulation services. Our exceptional track record includes supporting 1,000 clients and collaborating on over 2,000 compounds, showcasing our expertise in solid-state research, crystallization, pre-formulation, formulation development, and manufacturing. With a global presence encompassing three strategically located R&D centers in New Jersey (USA), Toronto (Canada), and Suzhou (China), we are powered by a skilled team of around 250 professionals. As a leader in both conventional and enabling formulation …

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

5 0 5 73
SpyBiotech SpyBiotech

Utilizing unique protein superglue technology to develop vaccines against infectious disease and cancer worldwide SpyBiotech is a UK-based company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases. SpyBiotech was spun out of the University of Oxford in 2017. Its proprietary protein superglue technology binds antigens to vaccine delivery platforms in a way which minimizes delivery risk and enhances immunogenicity and efficacy. The company’s current lead candidate is against human cytomegalovirus (HCMV), with clinical studies planned for this year. Vaccine Development

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

3 2 1 23
Discovery Park Discovery Park

A thriving life science community for entrepreneurs and leaders and the ideal environment for businesses to succeed 🧪 Discovery Park is the ideal environment for life science businesses to succeed. From state-of-the-art labs and offices to comprehensive support, we work in partnership with you to provide firm foundations for every stage of your growth. Within easy reach of London, our location provides access to a wealth of resources and opportunities with the freedom to expand, making it the optimal setting for brilliant minds to unlock the potential of scientific breakthroughs. Science, Technology, Manufacturing, Research , Research and Development, Enterprise, Logistics, …

Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology

21 1 20 62
Qkine Qkine

High quality and novel growth factors for stem cell and organoid culture, regenerative medicine and cellular agriculture Qkine manufactures high-quality and novel growth factors, supporting scientists in developing and scaling stem cell, organoid, cellular agriculture and regenerative medicine applications. We are also developing new growth factor technologies to enable emerging fields such as cultured meat and 3D cell culture. All Qkine high purity animal-free growth factor proteins are manufactured at our facility in Cambridge, UK . Extensive quality testing is conducted on every lot to guarantee reproducibility. Based on proprietary technology developed in the laboratory of Dr Marko Hyvönen, senior …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

9 3 9 39
Prokarium Prokarium

LIVING CURES Prokarium is pioneering the field of microbial immunotherapy. Our pipeline is designed to unlock the next level of immuno-oncology by building on the most recent advances in cancer immunology. Prokarium’s lead program is focused on transforming the treatment paradigm in bladder cancer by orchestrating immune-driven, long-lasting antitumor effects. Biotechnology, Vaccines, Oral delivery, Immunology, Synthetic Biology, Oncology, Microbial Immunotherapy, and Immunotherapy

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

5 0 2 22
Compass Pathways Compass Pathways

Our vision is a world of mental wellbeing We are Compass Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first clinical development programme is researching investigational COMP360 psilocybin treatment for patients with treatment-resistant depression. We want to transform the patient experience in mental health care.

Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

10 2 3 249
Deep Branch (acquired by Aerbio 2024) Deep Branch (acquired by Aerbio 2024)

Deep Branch was established in Nottingham (UK) in 2018 and built a gas fermentation platform for protein production. Deep Branch developed a patented technology platform that use carbon dioxide and hydrogen as feedstocks for fermentation, instead of sugar. The company was acquired by Aerbio in 2024. Carbon recycling, Single cell protein, Gas fermentation, Synthetic biology, Circular economy, Biobased economy, and Food Security

Type: Startup Activities: cleantech greentech Technologies: Bio sourced materials Decarbonization Synthetic Biology

17 2 12 12
Jellagen Jellagen

A Revolutionary Platform for Regenerative Medicine Our jellyfish collagen-based innovation addresses complex regenerative medical needs, shaping next generation treatments and supporting current and future scientific research. At the heart of our products is marine-sourced Collagen Type 0, an evolutionary ancient stem collagen that is foundational, allowing greater applications across multiple indications. Medical Grade Collagen, Native Collagen, Cell Culture Reagents, Wound Healing, Hydrogels, Non Mammalian Collagen, Collagen, Reagents, Marine Biotechnology, regenerative medicine, 3dscaffolds, collagencoatedplates, and 3dsponges

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

2 0 2 15
MeiraGTx MeiraGTx

Engineering Hope MeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical-stage genetic medicine company with a broad pipeline of late-stage clinical programs supported by end-to-end manufacturing capabilities. MeiraGTx has an internally developed manufacturing platform process, internal plasmid production for GMP, two GMP viral vector production facilities as well as an in-house Quality Control hub for stability and release, all fit for IND through commercial supply. MeiraGTx has core capabilities in viral vector design and optimization and a potentially transformative riboswitch gene regulation platform technology that allows for the precise, dose-responsive control of gene expression by oral small molecules. MeiraGTx is focusing …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

4 1 3 383
Motilent Motilent

Changing the way we see the gut Motilent is a technology SME focused on delivering innovative services for the quantitative investigation of the gut. Motilent champions the use of novel MRI post-processing software as a cheaper and safer biomarker for Gastrointestinal and Bowel Disorders, providing quantitative end points for research, drug development and clinical decision-making.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

6 1 6 21
Repositive - no longer trading Repositive - no longer trading

Accelerating biomedical research by connecting biopharmas with the right preclinical cancer models and CRO partners Repositive is committed to accelerating the development of precision cancer therapies to the clinic by working with biopharmas and Contract Research Organisations (CROs) to improve the predictivity of pre-clinical cancer research. Through its Cancer Models Scout service, Repositive is helping biopharmas to optimise their pre-clinical cancer projects by identifying the most suitable cancer models for their requirements from its world-leading database of over 8000 models, as well as via outreach to an extended network of CRO contacts. Repositive works to connect researchers with the right …

Type: Startup Activities: biotech deeptech it services Technologies: Synthetic Biology

9 2 7 1
Foundry3 Foundry3

Healthcare communications agency built on the three pillars of science, creativity and innovation We are a global healthcare communications agency built for a connected world. We seamlessly integrate online and offline channels to engage, educate and inform healthcare professionals and patients. We are driven by data, insight and robust science. Yet we communicate with passion, flair and empathy. Some clients use us as a medical agency, creative agency or digital agency. Regardless, we always bring all three disciplines to each and every project, just in different doses. You give us the challenge, and we build the solution around it. Medical …

Type: Startup Activities: deeptech biotech martech Technologies: Synthetic Biology

3 1 0 10
The Electrospinning Company Ltd. The Electrospinning Company Ltd.

Bringing Your Medical Device Design to Life. Electrospun Material Development, Validation, and Scale-Up We assist medical device manufacturers at every stage of their material development journey. From conducting feasibility studies to scaling up of your validated manufacturing process, we ensure that as the demand for your device grows, your electrospun material manufacturing process does, too. Since 2014, we have been transforming material concepts into scalable electrospun device material manufacturing processes that meet quality requirements. Our expertise lies in converting design requirements into medical-grade electrospun materials and components. We guide clients throughout their material development journey, starting with a feasibility study, …

Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology

3 1 2 21
Lightpoint Lightpoint

Improving patient outcomes with targeted cancer surgery Lightpoint is a technology leader in precision-guided robotic cancer surgery. We are developing miniaturized imaging and sensing tools for advanced intra-operative cancer detection. Our mission is to improve the lives of people with cancer by transforming the efficacy of robotic surgery. Lightpoint Medical was established in 2012 and in 2023 was acquired by Telix Pharmaceuticals and became Lightpoint - a Telix Company. https://telixpharma.com/news-views/telix-completes-acquisition-of-lightpoint-medical Medical imaging, Image-guided surgery, Molecular imaging, Surgical imaging, Intraoperative imaging, PET imaging, Surgical navigation, Medical device, robotic surgery, surgical robotics, robotics, and medtech

Type: Startup Activities: deeptech healthtech Technologies: Robotics Synthetic Biology

6 1 2 13
Idorsia Pharmaceuticals Ltd Idorsia Pharmaceuticals Ltd

Reaching out for more! The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients. We have more ideas, we see more opportunities, and we want to transform the horizon of therapeutic options. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options. See our LinkedIn community guidelines: https://www.idorsia.com/documents/com/policies-charters/idorsia-linkedin-community-guidelines.pdf Idorsia …

Type: Startup Activities: biotech Technologies: Synthetic Biology

1 1 0 995
Pet Drugs Online Pet Drugs Online

The UK's largest and most-trusted supplier of veterinary medicine and pet products. Helping you to love them well. Pet Drugs Online originated in the office of a small Bath veterinary surgery in 2005, with a simple yet ambitious goal: to help pet owners drastically reduce the cost of their pet healthcare. Over the course of 15 years, we have grown to become the largest and most trusted supplier of veterinary medicine in the UK, assisting millions of customers in finding the medicines, supplements, and food their pets need. At our core, we are not only pet owners, but passionate pet …

Type: SMB Activities: pettech healthtech Technologies: Synthetic Biology

0 0 0 66
TWIICE TWIICE

Enabling people to reconnect with their community by giving back access to life. TWIICE is an early stage start-up based in Lausanne, Switzerland. We develop and build customer-specific exoskeletons for walking assistance and rehabilitation of people with mobility issues. Our goal is to give back users the sensations and benefits of standing and walking as well as help them regain some independence in their daily activities.

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

7 2 4 8
Genenta Science Genenta Science

Permanent Self-Vaccination Against Cancer Genenta (Nasdaq: GNTA) is a clinical-stage biotechnology company engaged in the development of a proprietary hematopoietic stem cell therapy for the treatment of a variety of solid tumor cancers. TemferonTM is based on ex-vivo gene transfer into autologous Tie2+ hematopoietic stem/progenitor cells (HSPCs) to deliver immunomodulatory molecules directly via tumor-infiltrating monocytes/macrophages (Tie2 Expressing Monocytes - TEMs). Temferon, which is under investigation in a phase 1/2a clinical trial in newly diagnosed Glioblastoma Multiforme patients who have an unmethylated MGMT gene promoter (uMGMT-GBM), is designed to reach solid tumors, induce a durable immune response not restricted to pre-selected …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

7 0 2 25
Standard BioTools Standard BioTools

Providing essential, standardized tools to accelerate breakthroughs in human health Microfluidics | Cytometry | Imaging Fluidigm is now Standard BioTools. A company and a name that reflects our commitment to you and your research ... To unleash the power of essential, standardized tools that help the life science industry develop breakthrough medicines faster and better. We are evolving to better meet the needs of our customers, bridging a robust and established portfolio of next-generation technologies with an experienced team of leaders dedicated to operational excellence. Standard BioTools – Unleashing reliable tools to accelerate breakthroughs in human health • Providing trusted …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

6 1 6 965
Oncimmune Oncimmune

We understand disease through the lens of the immune system for more effective, safer treatments & better diagnosis Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based platform, delivers actionable insights into therapies to our pharmaceutical and biotech partners. Oncimmune’s ImmunoINSIGHTS platform enables life-science organisations to optimise drug development and delivery, leading to more effective targeted as well as safer treatments for patients. Oncimmune is headquartered in the UK, with a discovery research centre in Dortmund, …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

8 0 7 51
Kuano Kuano

Providing innovative quantum and AI solutions for drug discovery and design. Our discovery platform uniquely combines target quantum mapping and AI led chemistry to enable faster development of better drug candidates. Our unique approach tackles common challenges in both AI driven drug design and target driven drug discovery. Quantum Mapping of targets introduces selectivity from the start, producing superior candidates in fewer design rounds. Identifying better starting points for AI-led chemistry eliminates bottlenecks in the hit to candidate optimization phase. Generating better Enzyme Inhibitors by targeting Quantum Transition States. We work with enzyme inhibitors in a unique way, continually developing …

Type: SMB Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

2 1 2 19
KOELIS KOELIS

Advancing Prostate Care KOELIS has assisted urologists and radiologists from around the world in their routine clinical practice since 2006, providing the latest technology for personalized prostate cancer planning and management, from biopsy to active surveillance and treatment. Focused on developing advanced, targeted and less invasive solutions, KOELIS is committed to creating and bringing to the market a new paradigm in prostate cancer care, where physicians can offer the most personalized answers to their patients, avoiding any under or overtreatment and preserving quality of life. Thanks to cutting-edge imaging tools like Trinity® cartographer, which combines multiple imaging modalities with full …

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

12 7 5 112
LA CLINIQUE E-SANTÉ LA CLINIQUE E-SANTÉ

[Automatic translation follows] Mental health accessible to all, at every stage of your life We believe that psychological well-being is the foundation of the health capital of every human being. 💙 Our Mission: to create a more human and personalized approach to Mental Health to make it accessible to as many people as possible. The E-Health Clinic is: 🧠 A curative solution 🙂 A therapy based on writing, video and exchange with humans 🕑 An immersive approach 24/7 🚀 Effective care, fast results 🤝 The assurance of follow-up with an expert psychologist according to your problem 📱 Follow-up accessible everywhere, …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

2 1 1 24
Molecular Assemblies, Inc. Molecular Assemblies, Inc.

DNA Synthesis Uncompromised Molecular Assemblies, Inc. is a private life sciences company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The company’s patented Fully Enzymatic Synthesis (or FESTM), based on making DNA the way nature makes DNA, produces long, high quality, sequence-specific DNA reliably, affordably, and sustainably. FES technology will enable the reading and writing of DNA for many industries, including industrial synthetic biology and precision medicine, as well as emerging applications of nanomachines and bio-based electronics. Molecular Assemblies is headquartered in San Diego. *Fully Enzymatic Synthesis and FES are the trademarks of …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 0 0 47
ONA Therapeutics ONA Therapeutics

First-in-class ADCs tailor designed to attack advanced cancer Ona Therapeutics is pioneering the development of first-in-class antibody drug conjugates (ADCs) that exploit the molecular underpinnings of advanced cancer. We partner with renowned academics and clinicians to discover novel therapeutic targets from the unique biology of treatment refractory advanced cancer patients. Our approach combines privileged biology with Ona’s expertise in biologics. Together, we craft ADCs and antibody therapies, aiming to provide effective new treatments for patients with no remaining alternatives.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 0 1 36
Mereo BioPharma Mereo BioPharma

Mereo BioPharma is a clinical-stage company focused on developing & commercialising rare disease & oncology treatments. Welcome to Mereo BioPharma, we are an agile biopharmaceutical company, focused on finding and bringing to market therapies that will improve the lives of people living with a rare disease. We are driven by a true understanding of the critical nature of our mission. We harness the power of science; with our knowledge of the rare diseases we seek to treat and deep relationships with all our stakeholders to create new therapeutic possibilities for people who need them. We do this in a focused …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

3 0 2 45
Anima Biotech Anima Biotech

Anima is a Tech.Bio company at the intersection of mRNA biology and AI. We are advancing the mRNA Lightning platform for the discovery of small molecule mRNA drugs and novel mRNA biology targets. Built from the ground up with over a decade of expertise in mRNA biology, the platform integrates mRNA biology with AI imaging technologies to visualize the entire life cycle of mRNA in cells and decode the mRNA biology underlying a disease. Utilizing millions of images from both healthy and diseased cells, we train disease-specific mRNA image analysis neural networks to recognize a disease signature, an mRNA biology …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology A.I.

4 0 3 68
Dynocardia, Inc. Dynocardia, Inc.

Enlightened blood-pressure management Dynocardia is a biomedical device development company committed to satisfying critical unmet needs to improve healthcare worldwide. ViTrackTM, our lead diagnostic device, is powered our proprietary technology making it the only stand-alone, cuff-less device that allows for continuous, non-invasive blood pressure (cNIBP) measurement. Unlike conventional occlusive devices, ViTrack offers direct, beat-to-beat measurement of blood pressure that is wrist-wearable, mobile, and easy to use, with the accuracy of intra-arterial lines. ViTrack, with data-rich capability that includes heart rate, heart rhythm, and respiratory parameters in addition to blood pressure, enables early intervention prior to acute events. Biomedical, cardiovascular, cNIBP, …

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

4 1 0 20
NordicInfu Care AB NordicInfu Care AB

Nordic Infucare started its journey as an entrepreneurial company with the desire to do things differently. Mats Bergryd founded the business to offer specialized treatments in a home environment, serving patients who suffer from chronic disease. He chose that niche as he, after 20 years in the industry, had identified a gap between what was possible to achieve with smart technology and pharmaceuticals, and the actual results. Mats concluded that there was an opportunity to increase the quality of life for patients with chronic disease by closing the gap, and that it would be good business for the one who …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

1 1 0 135
miRecule, Inc. miRecule, Inc.

RNA Therapeutics We develop first-in-class RNA-based therapies, with lead programs in Head & Neck Squamous Cell Carcinoma (HNSCC) and Facioscalpulohumeral Muscular Dystrophy (FSHD). Our approach to drug design revolves around using genomic patient data to create highly tailored therapeutics – the right drug for the right patient. Our proprietary DREAmiRTM platform utilizes genomic and outcome data from thousands of patients to identify underlying genetic changes that cause their disease, and then creates a novel RNA therapeutic that can directly target and fix that genetic abnormality.

Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology Data Analytics

2 2 1 19
Eurofins Viracor Eurofins Viracor

Get results faster, when it matters most. It’s so much more than a specimen. It's a life. With over 30 years of specialized expertise in infectious disease, immunology, transplant, and allergy testing for immunocompromised and critical patients, Eurofins Viracor is committed to helping medical professionals, transplant teams, reference labs and biopharmaceutical companies get results faster, when it matters most. Eurofins Viracor is passionate about providing timely, actionable test results, never losing sight of the connection between the testing we perform and the patients our results ultimately serve. Find out more by visiting us at www.eurofins-viracor.com/clinical Eurofins Viracor is an equal …

Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

1 1 0 268
PhaBuilder PhaBuilder

An leading synthetic biotechnology company focusing on the green manufacturing of biodegradable plastic PHAs. PhaBuilder is a company with leading synthetic biotechnology, focusing on the transformation and engineering of halophilic microorganisms. PhaBuilder was founded in February 2021 by Professor Guoqiang Chen, director of the Center for Synthesis and Systems Biology at Tsinghua University. It mainly uses the cutting-edge "Next Generation Industrial Biotechnology(NGIB)" to develop and produce a variety of high-value-added products such as PHA - a biodegradable material, ectoine - a pharmaceutical intermediate, and cadaverine - a Nylon 56 precursor. PhaBuilder currently has two PHA plants under construction - the …

Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology

4 2 4 17
Genomadix Genomadix

Lab Quality Results Without The Lab! Revolutionizing diagnostics with fast, portable, and accurate DNA results. Based in Ottawa, Canada, Genomadix Inc. is a pioneer in real-time qPCR point of need technology, dedicated to the highest level of customer satisfaction, quality, and support, maintaining ISO 13485 medical device development and manufacturing standards certification. The Genomadix Cube is a real-time polymerase chain reaction (PCR) molecular diagnostic instrument capable of performing tests for precision medicine genotyping and environmental targets on a sample-to-result platform. The portable size, ease of use, and on-demand processing capability enables users to generate time-critical results in approximately one hour. …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 32
REGEMAT 3D REGEMAT 3D

Customized Bioprinting systems and Bioreactors. Creating Life Changing Futures. From Researcher to Researchers. REGEMAT3D develops customized Bioprinting Systems and Bioreactors - BMAP. We create Living Tissue Technologies. The potential of bioprinting in regenerative medicine and tissue engineering is huge. There are still many problems to be solved and many hypothesis to be tested in order to find solutions to tissue regeneration. Our mission is to develop innovative solutions in the area of bioprinting and regenerative medicine towards the clinical application of this amazing technology, to improve people ́s quality of life. bioprinting, regenerative medicine, biotechnology, and tissue engineering

Type: Startup Activities: biotech deeptech Technologies: 3D Printing Synthetic Biology

5 0 2 25
Aptamer Group Aptamer Group

We develop Optimer® binders to enable innovation across the life science industry. Aptamer Group develops Optimer® binders to enable innovation in the life science industry. Get our newsletter: https://aptamergroup.com/newsletter Research and Development, Assay Development, Custom development, Drug development, Custom reagents, Agriculture testing, Aptamers, Biomarker discovery, Affinity ligands, Environmental testing, Affinity chromatography ligands, ADCs / AOCs, QC reagents, Diagnostic tools, and Targeted delivery

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

4 0 4 37
Colorifix Colorifix

Unlocking nature's pigments for the global dyeing industry We bring colour to life. Colorifix has developed a revolutionary dyeing process to help the textile industry dramatically reduce its environmental impact in a cost-effective manner. Using synthetic biology we produce, deposit and fix dyes biologically, avoiding harmful chemicals whilst reducing water, energy and waste. Let's rethink industrial dyeing. Contact us today to discuss how Colorifix can fulfil your coloration requirements.

Type: Startup Activities: fashtech manufacturing Technologies: Bio sourced materials Decarbonization Synthetic Biology

13 5 11 96
Medherant Limited Medherant Limited

Medherant is a clinical-stage company developing innovative treatments using its novel transdermal drug delivery technology, the TEPI Patch, which is based on a proprietary adhesive developed by its scientists. The Company was founded by Professor David Haddleton and the University of Warwick in 2015 based on their world-leading expertise in bioadhesives and polymer chemistry. The adhesive has a high drug loading capacity, so a smaller quantity of adhesive is needed to deliver a therapeutic dose; the patch can therefore be thinner and more flexible. It also enables excipients, such as permeation enhancers, to be included in the adhesive so the …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

2 0 1 16
TrakCel TrakCel

Transforming Cellular Orchestration for Cell & Gene Therapy. Join us. See the journey. TrakCel design, deploy and support digital Cellular Orchestration Solutions that track and manage all the components of the Cell and Gene Therapy supply chain, helping therapy developers to deliver therapies to patients safely and efficiently for both clinical and commercial stage therapies. For each Advance Therapy Patient journey, from sample collection through logistics, manufacturing and final treatment, TrakCel's flagship platform, OCELLOS orchestrates every step, providing a comprehensive chain of custody, chain of identity and traceability throughout. Always remembering there is a patient at the end of everything …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

8 1 6 96
PBD Biotech PBD Biotech

PBD Biotech develops Actiphage, a blood test that detects 'active', disease-causing tuberculosis infection. PBD Biotech develops Actiphage, a blood test that detects 'active', disease-causing tuberculosis infection. One quarter of the world’s population is infected with latent tuberculosis (LTBI), also known as inactive tuberculosis. One in ten people with LTBI will progress to active TB disease. It is essential to develop newer diagnostic tests with significantly increased predictive value for the development of active disease among those who are infected than the currently available tests for LTBI (WHO, 2017). At PBD Biotech, our mission is to support the scale-up of latent …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

9 1 5 12
Green Common Green Common

Green Common is the world’s first plant-based concept store to create a revolutionary food and lifestyle experience by introducing some of the most advanced global foodtech innovations. Its sales network has spread to over 10 countries and regions. Vegan, vegetarian, sustainability, food technology, food innovation, wholesale, distribution, marketing, branding, nutrition, green solution, corporate solutions, plant based, food 2.0, Beyond Burger, Marketing, Catering, Omnipork, and Alternative Protein

Type: Startup Activities: foodtech Technologies: Synthetic Biology

0 0 0 20
Neumora Neumora

Pioneering a new era of medicines for brain diseases Brain diseases collectively represent one of the largest areas of unmet medical need, affecting upwards of 1.5 billion patients globally. Neumora was founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. Our goal is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment outcomes and quality of life for patients. We’ve built a pipeline comprised of programs for neuropsychiatric disorders and neurodegenerative diseases, each targeting a novel mechanism …

Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

2 0 2 128
Biotrains Biotrains

CONNECT COLLABORATE EVOLVE Biotrains is world's leading provider of business conferences, training, managed events and Consulting services for Pharmaceutical, Biotech, Healthcare and Medical Device industry. We at Biotrains recognize that knowledge is power and continuous learning is fundamental for the success of all business and academia. We deliver world-class content and expert knowledge that our clients demand to outshine in their professional roles giving a competitive advantage to their organization. We organize specialized technical events in areas including • Lyophilization/Freeze Drying • Bioprocess Development & Manufacturing • Drug Development, Drug Discovery • Diagnostics & Personalized Medicine • Healthcare, Home Healthcare …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

4 0 4 35
Béa Fertility Béa Fertility

Startup building the first clinical grade fertility treatment | Increasing access to effective and affordable treatments The future of fertility care is here. Affordable, at-home ICI-based fertility treatment designed to help you get you pregnant. Fertility and Medical Device

Type: Startup Activities: healthtech Technologies: Synthetic Biology

5 2 2 17
Bicycle Therapeutics Bicycle Therapeutics

Precision-Guided Therapeutics Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company that is harnessing the power of bicyclic peptides and leveraging Nobel Prize-winning science to develop a new and differentiated class of medicines to treat cancer and other diseases. Bicycle® molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycle molecules attractive candidates for drug development. The company is evaluating zelenectide pevedotin, previously BT8009, a Bicycle® Toxin Conjugate (BTC®) targeting Nectin-4, a well-validated tumor antigen; BT5528, a BTC …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

7 2 2 283
Aptissen SA Aptissen SA

Aptissen delivers orthobiologic solutions to joint medical specialists. Aptissen S.A. is a Swiss company specialized in the development and commercialization of biopolymer-based medical devices. Aptissen’s founders have developed for the past 25 years the best quality injectable products which meet both patients and doctors expectations: www.aptissen.com The company was founded in 2013 as a spin-off of ANTEIS, and is based in Geneva area, Switzerland. It today distributes its products through a worldwide international distributors'​ network among more than 90 countries including Europe, South America, Canada, Middle East and Asia. Aptissen's team revolutionized the viscosupplement market with Synolis VA and his …

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

1 0 1 49
Twist Bioscience Twist Bioscience

Synthetic DNA for Health & Sustainability Twist Bioscience is a synthetic biology company based in South San Francisco, California. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA. Twist Bioscience serves Life Science researchers who are changing the world for the better. Coming from diverse fields of medicine, agriculture, industrial chemicals and data storage, scientists use our synthetic genes, oligo pools, and NGS target enrichment to better lives and improve the sustainability of the planet. Twist Bioscience is uniquely positioned to help accelerate these efforts by providing precision at a scale that is otherwise …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

27 6 18 1,071
Daiichi Sankyo Europe GmbH Daiichi Sankyo Europe GmbH

Passion for Innovation. Compassion for Patients. Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people around the world by leveraging our world-class science and technology. In Europe, we want to become the benchmark for customer centricity in the areas we work in and a competitive player in Oncology. For these reasons we are constantly looking for new talents that are willing to deliver the best solutions to the various healthcare professionals who aim to provide their patients with the best possible therapy - …

Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

5 2 1 995
TOMZ Corporation TOMZ Corporation

An industry leading manufacturer of life-changing medical devices and implants. ISO 13485:2016 Certified & FDA Registered TOMZ Corporation was founded in 1988 and is a leader in the manufacturing of precision components for major medical device, healthcare and laboratory diagnostics. We have been able to maintain private ownership and operation since inception and will continue into the next generation. With 200,000+ square feet, our facilities across Connecticut, Indiana and Minnesota house state of the art, validated CNC Lathe/Mill/Wire EDM, Finishing, Passivation/Anodize, Inspection, to Package & Label. We are truly your "one stop shop."​ TOMZ understands and works closely with our …

Type: SMB Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology

0 0 0 142
Spexis AG Spexis AG

Life-changing therapies for rare disease and oncology patients. Merger between EnBiotix Inc. and Polyphor AG. Spexis AG (SIX:SPEX) is a publicly-listed Swiss clinical-stage biopharmaceutical company developing rare disease and oncology treatments in indications where new therapeutic options are urgently needed. Spexis AG was launched in December 2021 by the reverse merger of EnBiotix, Inc. (Boston, MA, USA) and Polyphor AG (Allschwil, Switzerland), with EnBiotix shareholders resulting in the majority. Our focus is on chronic respiratory diseases (CRD), and our lead product candidate ColiFin® is P3 ready. ColiFin® is an inhaled colistimethate sodium product in-licensed from PARI Pharma GmbH for ex-European …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 24
Sequana Medical NV Sequana Medical NV

Pioneers in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer Sequana Medical NV is a pioneer in treating drug-resistant fluid overload, a serious and frequent clinical complication in patients with liver disease, heart failure and cancer. Fluid overload is a well-recognized problem in these growing diseases, causing severe problems for the large number of patients for whom current medicines are no longer effective. These patients can have up to 15 liters of extra fluid in their bodies, causing major medical issues including increased mortality, repeated hospitalizations, severe pain, difficult breathing and restricted mobility that severely …

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

0 0 0 53
Oryzon Genomics SA Oryzon Genomics SA

Pioneering personalized medicine in epigenetics Oryzon Genomics, S.A. is a clinical stage biopharmaceutical company and the European leader in the development of epigenetics-based therapeutics, with a strong focus on personalized medicine approaches to CNS disorders and oncology. Oryzon has a broad and growing portfolio, with two compounds in clinical trials: iadademstat, a highly potent and selective LSD1 inhibitor, in Phase IIa clinical trials for the treatment of acute myeloid leukemia and small cell lung cancer, and vafidemstat, a CNS optimized LSD1 inhibitor in multiple Phase II trials for the treatment of CNS and psychiatric diseases. Phase IIb trials for both …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

0 0 0 56
Immatics Immatics

Delivering the Power of T Cells to Cancer Patients Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry. We are committed to delivering the power of T cells and to unlocking new avenues for patients in their fight against cancer. Read more about Immatics on our homepage: …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

1 1 0 519
Compugen Compugen

A clinical-stage cancer immunotherapy company and a pioneer in computational target discovery Compugen is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify new drug targets and biological pathways for developing cancer immunotherapies. Compugen has developed two proprietary product candidates: COM701, a potential first-in-class anti-PVRIG antibody and COM902, a potential best-in-class antibody targeting TIGIT for the treatment of solid tumors. Compugen also has a clinical stage partnered program, rilvegostomig (previously AZD2936), a PD-1/TIGIT bispecific antibody where the TIGIT component is derived from Compugen’s clinical stage anti-TIGIT antibody, COM902, in Phase 3 development …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

16 1 13 106